Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background: Optimal interventions to prevent or delay cognitive decline, mild cognitive impairment (MCI), or dementia are uncertain. Purpose: To summarize the evidence on efficacy and harms of over-the-counter (OTC) supplements to prevent or delay cognitive decline, MCI, or clinical Alzheimer-type dementia in adults with normal cognition or MCI but no dementia diagnosis. Data Sources: Multiple electronic databases from 2009 to July 2017 and bibliographies of systematic reviews. Study Selection: English-language trials of at least 6 months' duration that enrolled adults without dementia and compared cognitive outcomes with an OTC supplement versus placebo or active controls. Data Extraction: Extraction performed by a single reviewer and confirmed by a second reviewer; dual-reviewer assessment of risk of bias; consensus determination of strength of evidence. Data Synthesis: Thirty-eight trials with low to medium risk of bias compared ω-3 fatty acids, soy, ginkgo biloba, B vitamins, vitamin D plus calcium, vitamin C or β-carotene, multi-ingredient supplements, or other OTC interventions with placebo or other supplements. Few studies examined effects on clinical Alzheimer-type dementia or MCI, and those that did suggested no benefit. Daily folic acid plus vitamin B12 was associated with improvements in performance on some objectively measured memory tests that were statistically significant but of questionable clinical significance. Moderate-strength evidence showed that vitamin E had no benefit on cognition. Evidence about effects of ω-3 fatty acids, soy, ginkgo biloba, folic acid alone or with other B vitamins, β-carotene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements was either insufficient or low-strength, suggesting that these supplements did not reduce risk for cognitive decline. Adverse events were rarely reported. Limitation: Studies had high attrition and short follow-up and used a highly variable set of cognitive outcome measures. Conclusion: Evidence is insufficient to recommend any OTC supplement for cognitive protection in adults with normal cognition or MCI. Primary Funding Source: Agency for Healthcare Research and Quality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review of the use of supplements, including vitamins C, D and E, omega-3 fatty acids and ginkgo biloba, found little to no benefit in preventing cognitive decline, MCI or Alzheimer's dementia.138”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [138]
In the citing paper
“No single food, beverage, ingredient, vitamin or supplement has been proven to prevent or cure Alzheimer's or any other dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [146]
Citations
Cites
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758 · cited 1×
“8 mg) compared with placebo over 3 years (31).”
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
Qato, D. M., Wilder, J., Schumm, L. P., Gillet, V., & Alexander, G. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8581 · Cited by 658
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive decline
Yurko‐Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A., Salem, N., Stedman, M., & MIDAS Investigators (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.01.013 · Cited by 579 · cited 5×
“One study used only docosahexaenoic acid (DHA) (17); all others used some combination of eicosapentaenoic acid (EPA) plus DHA.”
InfluentialPreventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment
Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., E. Nichols, T., Smith, S. M., & Smith, A. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301816110 · Cited by 515
de Jager, C. A., Oulhaj, A., Jacoby, R., Refsum, H., & Smith, A. D. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2758 · Cited by 457
Witte, A. V., Kerti, L., Margulies, D. S., & Floel, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0385-14.2014 · Cited by 455 · cited 1×
“Evidence was insufficient to draw conclusions for dehydroepiandrosterone (n = 227) (51), red clover (n = 30) (52), resveratrol (n = 46) (53), and plant sterols or stanols (n = 57) (54) for adults with presumed normal cognition because of the small size of the single studies for each of these interventions.”
Kreijkamp-Kaspers, S., Kok, L., Grobbee, D. E., de Haan, E. H. F., Aleman, A., Lampe, J. W., & van der Schouw, Y. T. (2004) · JAMA · doi:10.1001/jama.292.1.65 · Cited by 438
Vellas, B., Coley, N., Ousset, P.-J., Berrut, G., Dartigues, J.-F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70206-5 · Cited by 398 · cited 6×
“Age inclusion criteria were older than 70 years (29), older than 75 years (26, 28), and older than 85 years (27).”
InfluentialA Controlled Trial of Homocysteine Lowering and Cognitive Performance
McMahon, J. A., Green, T. J., Skeaff, C. M., Knight, R. G., Mann, J. I., & Williams, S. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054025 · Cited by 396 · cited 4×
“Evidence was insufficient to conclude a possible effect of treatment on executive function, attention, and processing speed (34).”
InfluentialEffect of fish oil on cognitive performance in older subjects: A randomized, controlled trial
van de Rest, O., Geleijnse, J. M., Kok, F. J., van Staveren, W. A., Dullemeijer, C., OldeRikkert, M. G. M., Beekman, A. T. F., & de Groot, C. P. G. M. (2008) · Neurology · doi:10.1212/01.wnl.0000324268.45138.86 · Cited by 382
Balk, E. M., Earley, A., Raman, G., Avendano, E. A., Pittas, A. G., & Remington, P. L. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0452 · Cited by 371
Snitz, B. E. (2009) · JAMA · doi:10.1001/jama.2009.1913 · Cited by 336
Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults
Witte, A. V., Kerti, L., Hermannstädter, H. M., Fiebach, J. B., Schreiber, S. J., Schuchardt, J. P., Hahn, A., & Flöel, A. (2014) · Cerebral Cortex · doi:10.1093/cercor/bht163 · Cited by 328 · cited 2×
“Five trials reported cognitive exclusion criteria, including a Mini-Mental State Examination (MMSE) score less than 22 (14, 15), less than 24 (13), or less than 26 (16, 17) out of a possible 30 points.”
Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29121 · Cited by 296 · cited 2×
“Five trials reported cognitive exclusion criteria, including a Mini-Mental State Examination (MMSE) score less than 22 (14, 15), less than 24 (13), or less than 26 (16, 17) out of a possible 30 points.”
Kryscio, R. J., Abner, E. L., Caban-Holt, A., Lovell, M., Goodman, P., Darke, A. K., Yee, M., Crowley, J., & Schmitt, F. A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5778 · Cited by 295 · cited 3×
“The study of men reported no difference in incidence of dementia at 10 years (lowstrength evidence) (42) but reported no other cognitive outcomes.”
Malouf, R., & Grimley Evans, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004514.pub2 · Cited by 277
A Randomized Trial of Vitamin E Supplementation and Cognitive Function in Women
Kang, J. H. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2462 · Cited by 227
Omega 3 fatty acid for the prevention of cognitive decline and dementia
Sydenham, E., Dangour, A. D., & Lim, W.-S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005379.pub3 · Cited by 222
Lee, L. K., Shahar, S., Chin, A.-V., & Yusoff, N. A. M. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2848-0 · Cited by 219
Kritz-Silverstein, D., Von M??hlen, D., Barrett-Connor, E., & Bressel, M. A. B. (2003) · Menopause · doi:10.1097/00042192-200310030-00004 · Cited by 210
Calcium and Vitamin D Supplementation and Cognitive Impairment in the Women's Health Initiative
Rossom, R. C., Espeland, M. A., Manson, J. E., Dysken, M. W., Johnson, K. C., Lane, D. S., LeBlanc, E. S., Lederle, F. A., Masaki, K. H., & Margolis, K. L. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12032 · Cited by 170
Walker, J. G., Batterham, P. J., Mackinnon, A. J., Jorm, A. F., Hickie, I., Fenech, M., Kljakovic, M., Crisp, D., & Christensen, H. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007799 · Cited by 165 · cited 2×
“One trial (n = 2919) recruited persons with presumed B12 deficiency (elevated homocysteine levels ≥12 μmol/L) (32).”
Stott, D. J., MacIntosh, G., Lowe, G. D. O., Rumley, A., McMahon, A. D., Langhorne, P., Tait, R. C., O’Reilly, D. S. J., Spilg, E. G., MACDONALD, J. B., et al. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1320 · Cited by 163 · cited 1×
“Two additional studies involving persons with normal cognition examined treatment effects on cognitive outcomes for other multivitamin or multi-ingredient interventions, but evidence was not assessed because of the small size of the studies (48, 49).”
McCleery, J., Abraham, R. P., Denton, D. A., Rutjes, A. W., Chong, L.-Y., Al-Assaf, A. S., Griffith, D. J., Rafeeq, S., Yaman, H., Malik, M. A., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011905.pub2 · Cited by 162
Oulhaj, A., Jernerén, F., Refsum, H., Smith, A. D., & de Jager, C. A. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150777 · Cited by 159
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
Dodge, H. H., Zitzelberger, T., Oken, B. S., Howieson, D., & Kaye, J. (2008) · Neurology · doi:10.1212/01.wnl.0000303814.13509.db · Cited by 155
Kang, J. H., Cook, N. R., Manson, J. E., Buring, J. E., Albert, C. M., & Grodstein, F. (2009) · Circulation · doi:10.1161/circulationaha.108.816900 · Cited by 136 · cited 4×
“Results were extracted at 4 years for both studies in women because of higher attrition at later time points (40, 41).”
InfluentialSi, G., Preuss, U. W., Wong, J. W. M., Hoerr, R., Kaschel, R., Bachinskaya, N. Y., & the GIMCIPlus Study Group (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4103 · Cited by 132 · cited 1×
“A 6-month study (n = 160) showed a small benefit with ginkgo biloba compared with placebo in 2 measures of executive function, attention, and processing speed (30).”
Long-term soy isoflavone supplementation and cognition in women: A randomized, controlled trial
Henderson, V. W., St. John, J. A., Hodis, H. N., Kono, N., McCleary, C. A., Franke, A. A., & Mack, W. J. (2012) · Neurology · doi:10.1212/wnl.0b013e318258f822 · Cited by 124
Dangour, A. D., Whitehouse, P. J., Rafferty, K., Mitchell, S. A., Smith, L., Hawkesworth, S., & Vellas, B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-090940 · Cited by 123
Kato-Kataoka, A., Sakai, M., Ebina, R., Nonaka, C., Asano, T., & Miyamori, T. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-62 · Cited by 112 · cited 1×
“Evidence was insufficient to determine any beneficial effect on cognitive outcomes from soybeanderived phosphatidylserine at 2 doses (100 and 300 mg daily) compared with placebo after 9 months in a single small study of adults with MCI (n = 78) (22).”
Geleijnse, J. M., Giltay, E. J., & Kromhout, D. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.06.002 · Cited by 111 · cited 4×
“Five trials reported cognitive exclusion criteria, including a Mini-Mental State Examination (MMSE) score less than 22 (14, 15), less than 24 (13), or less than 26 (16, 17) out of a possible 30 points.”
InfluentialLong-Term Multivitamin Supplementation and Cognitive Function in Men: A Randomized Trial
Grodstein, F., O’Brien, J., Kang, J. H., Dushkes, R., Cook, N. R., Okereke, O., Manson, J. E., Glynn, R. J., Buring, J. E., Gaziano, J. M., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00006 · Cited by 110 · cited 5×
“In 3 trials, cognitive results did not differ by lifestyle factors, including smoking history, alcohol use, fruit and vegetable intake, or nutritional deficiency (not defined) (44, 46, 47).”
InfluentialGleason, C. E., Carlsson, C. M., Barnet, J. H., Meade, S. A., Setchell, K. D. R., Atwood, C. S., Johnson, S. C., Ries, M. L., & Asthana, S. (2008) · Age and Ageing · doi:10.1093/ageing/afn227 · Cited by 100 · cited 2×
“Populations included older adults without dementia (20) and generally healthy postmenopausal women (21, 23–25).”
Andreeva, V. A., Kesse‐Guyot, E., Barberger‐Gateau, P., Fezeu, L., Herçberg, S., & Galan, P. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.006320 · Cited by 99 · cited 7×
“Low-strength evidence showed no difference between the treatment and placebo groups in brief cognitive test performance or memory (12, 34).”
InfluentialHo, S. C., Chan, A. S. Y., Ho, Y. P., So, E. K. F., Sham, A., Zee, B., & Woo, J. L. F. (2007) · Menopause · doi:10.1097/gme.0b013e31802c4f4f · Cited by 93 · cited 3×
“Two studies reported no serious adverse events and no statistically significant differences in adverse events between the soy and placebo groups (21, 25).”
Kritz‐Silverstein, D., Von Mühlen, D., Laughlin, G. A., & Bettencourt, R. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01768.x · Cited by 92 · cited 1×
“Evidence was insufficient to draw conclusions for dehydroepiandrosterone (n = 227) (51), red clover (n = 30) (52), resveratrol (n = 46) (53), and plant sterols or stanols (n = 57) (54) for adults with presumed normal cognition because of the small size of the single studies for each of these interventions.”
Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT
van der Zwaluw, N. L., Dhonukshe-Rutten, R. A. M., van Wijngaarden, J. P., Brouwer-Brolsma, E. M., van de Rest, O., In 't Veld, P. H., Enneman, A. W., van Dijk, S. C., Ham, A. C., Swart, K. M. A., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001050 · Cited by 88 · cited 2×
“Post hoc subgroup analyses found a slight benefit for memory with folic acid and B12 compared with placebo in participants with low baseline levels of holotranscobalamin (another biomarker associated with vitamin B deficiency) (33).”
McNeill, G., Avenell, A., Campbell, M. K., Cook, J. A., Hannaford, P. C., Kilonzo, M. M., Milne, A. C., Ramsay, C. R., Seymour, D. G., Stephen, A. I., et al. (2007) · Nutrition Journal · doi:10.1186/1475-2891-6-10 · Cited by 84 · cited 3×
“In 3 trials, cognitive results did not differ by lifestyle factors, including smoking history, alcohol use, fruit and vegetable intake, or nutritional deficiency (not defined) (44, 46, 47).”
Strike, S. C., Carlisle, A., Gibson, E. L., & Dyall, S. C. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv109 · Cited by 82 · cited 2×
“Two trials assessed the effect of baseline cognition, education, prior supplement use, and comorbidities on cognitive outcomes (46, 48).”
Wolters, M., Hickstein, M., Flintermann, A., Tewes, U., & Hahn, A. (2005) · Preventive Medicine · doi:10.1016/j.ypmed.2004.11.007 · Cited by 72
Naeini, A. A., Elmadfa, I., Djazayery, A., Barekatain, M., Aghaye-Ghazvini, M. R., Djalali, M., & Feizi, A. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0628-1 · Cited by 71 · cited 1×
“Evidence was insufficient to determine any benefit of combined daily vitamin E (300 mg) and vitamin C (400 mg) on cognitive outcomes compared with placebo after 1 year in a single study of adults with MCI (n = 256) (50).”
Cukierman-Yaffe, T., Bosch, J., Diaz, R., Dyal, L., Hancu, N., Hildebrandt, P., Lanas, F., Lewis, B. S., Marre, M., Yale, J.-F., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70062-2 · Cited by 64 · cited 4×
“Of 67 reported cognitive tests— including 9 brief cognitive tests (12, 14, 17, 18); 1 test of multidomain neuropsychological performance (13); 32 tests of executive function, attention, and processing speed (13, 15–18); and 25 memory tests (13, 15– 17)—only 5 showed scores that were statistically significantly better…”
InfluentialHowes, J. B., Bray, K., Lorenz, L., Smerdely, P., & Howes, L. G. (2004) · Climacteric · doi:10.1080/13697130310001651490 · Cited by 57 · cited 1×
“Evidence was insufficient to draw conclusions for dehydroepiandrosterone (n = 227) (51), red clover (n = 30) (52), resveratrol (n = 46) (53), and plant sterols or stanols (n = 57) (54) for adults with presumed normal cognition because of the small size of the single studies for each of these interventions.”
Schiepers, O. J. G., de Groot, R. H. M., van Boxtel, M. P. J., Jolles, J., de Jong, A., Lütjohann, D., Plat, J., & Mensink, R. P. (2009) · Journal of Nutrition · doi:10.3945/jn.108.103721 · Cited by 29
Ginkgo biloba for prevention of dementia: a systematic review and meta-analysis.
Charemboon, T., & Jaisin, K. (2015) · PubMed · Cited by 25
Abraham, R. P., Denton, D. A., Al-Assaf, A. S., Rutjes, A. W., Chong, L. Y., Malik, M., & Tabet, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011905 · Cited by 16
Research works printed but not linked: 1
- Charemboon T, 2015, J Med Assoc Thai, 98, 508
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
“A systematic review [40] of the use of supplements, including (but not limited to) C, D and E vitamins, omega-3 fatty acids, and ginkgo biloba, found little to no benefit of over-the-counter supplements in preventing cognitive decline, MCI or Alzheimer’s dementia.”
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
Metadata
- Authors
- Butler, M., Nelson, V. A., Davila, H., Ratner, E., Fink, H. A., Hemmy, L. S., McCarten, J. R., Barclay, T. R., Brasure, M., & Kane, R. L.
- Affiliations
- University of Minnesota (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2018-01-02
- Volume
- 168
- Issue
- 1
- Pages
- 52-62
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2778293650
- Cited by
- 144
- References
- 52
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 17 · 2023: 16 · 2022: 17 · 2021: 25 · 2020: 20 · 2019: 21 · 2018: 11
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- over-the-counter supplements, cognitive decline, mild cognitive impairment, Alzheimer-type dementia, dementia prevention, omega-3 fatty acids, soybean, Ginkgo biloba, B vitamins, folic acid, vitamin B12, vitamin E, beta-carotene, vitamin C, multivitamins, memory, adverse events
- MeSH terms
- Alzheimer Disease, Nonprescription Drugs, Humans, Dietary Supplements, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.